Krystal Biotech received FDA RMAT designation for inhaled KB707 in advanced NSCLC, based on a 36% ORR in heavily pretreated ...
Q4 recap: revenue beat but margins missed; weaker EPS/FCF guidance. MV-75 adds upside with near-term risk. Read more macro ...
The 2025 NFL season is in the rear-view mirror, which means free agency speculation and mock draft seasons are here. Last ...
Researchers at Åbo Akademi University have identified a new molecular change in patients with colorectal cancer and developed ...
Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that IP ...
Sitka Gold Corp. (TSXV: SIG) (FSE: 1RF) (OTCQB: SITKF) ("Sitka" or the "Company") is pleased to announce the immediate appointment of Louis Archambeault to its Board of Directors as an independent ...
Who said the season is just for skiing? From Miami Beach to California wine country, here are the openings on our radars.